Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2017, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2017-06-19
DOI
10.1155/2017/1485283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma
- (2017) Bernhard Gillissen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of the in vitro effect of Boldo and Meadowsweet plant extracts on the expression of antimicrobial peptides and inflammatory markers in canine keratinocytes
- (2017) Domenico Santoro et al. RESEARCH IN VETERINARY SCIENCE
- Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells
- (2017) Daniel Bauer et al. Cell Death & Disease
- Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS
- (2016) Ruohan Zhang et al. CANCER BIOLOGY & THERAPY
- ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
- (2016) Haiquan Lu et al. CANCER LETTERS
- Triggering of Suicidal Erythrocyte Death by Pazopanib
- (2016) Elena Signoretto et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: Involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway
- (2016) Shijie Cao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy
- (2016) Néstor Prieto-Domínguez et al. JOURNAL OF PINEAL RESEARCH
- Targeted therapy: An elusive cancer target
- (2016) Carolyn Brown NATURE
- A PGC1α-mediated transcriptional axis suppresses melanoma metastasis
- (2016) Chi Luo et al. NATURE
- The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
- (2016) Stéphanie Anaís Castaldo et al. Oxidative Medicine and Cellular Longevity
- NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies
- (2016) Hilal S. Khalil et al. Oxidative Medicine and Cellular Longevity
- Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress
- (2016) Hesham M. Korashy et al. TOXICOLOGY LETTERS
- A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
- (2016) Hilal S. Khalil et al. Oncotarget
- Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
- (2016) Suk-young Lee et al. Biomed Research International
- Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways
- (2016) Fenglian Shan et al. Cancer Medicine
- The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma
- (2015) Beth A. Christian et al. BRITISH JOURNAL OF HAEMATOLOGY
- Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions
- (2015) Sebastian Bauer et al. DRUGS
- Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway
- (2015) Alessandra Leone et al. FREE RADICAL BIOLOGY AND MEDICINE
- Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer
- (2015) L.G.T. Lemos et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells
- (2015) Imoh S. Okon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
- (2015) Francesca Megiorni et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension
- (2015) Anna M.J. Thijs et al. JOURNAL OF HYPERTENSION
- Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism
- (2015) Victor Tkachev et al. JOURNAL OF IMMUNOLOGY
- Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
- (2015) Helen Gharwan et al. Nature Reviews Clinical Oncology
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
- (2015) Paweorn Angsutararux et al. Oxidative Medicine and Cellular Longevity
- An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
- (2015) Takatoshi Karasawa et al. TOXICOLOGY LETTERS
- Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction
- (2015) Akram Sadeghirizi et al. TUMOR BIOLOGY
- Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells
- (2015) Maria Beatrice Morelli et al. Oncotarget
- The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
- (2015) Valentina Tesori et al. Scientific Reports
- Mitochondrial oxidative stress is the achille’s heel of melanoma cells resistant to Braf-mutant inhibitor
- (2015) Paola Corazao-Rozas et al. Oncotarget
- Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
- (2014) Fred Fack et al. ACTA NEUROPATHOLOGICA
- Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
- (2014) M M Wattenberg et al. BRITISH JOURNAL OF CANCER
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries
- (2014) Amal Kamal Abdel-Aziz et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Sunitinib Produces Neuroprotective Effect Via Inhibiting Nitric Oxide Overproduction
- (2014) Wei Cui et al. CNS Neuroscience & Therapeutics
- Involvement of superoxide and nitric oxide in BRAFV600E inhibitor PLX4032-induced growth inhibition of melanoma cells
- (2014) Ling Yu et al. Integrative Biology
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Genetic System Based on Zinc Finger Nucleases for the Identification of Interactions between Proteins In Vivo
- (2014) Ling Wang et al. PLoS One
- Effects of Everolimus on Oxidative Stress in Kidney Model of Ischemia/Reperfusion Injury
- (2013) Aleksandra Kezic et al. AMERICAN JOURNAL OF NEPHROLOGY
- Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients
- (2013) Katharina Rosing et al. ATHEROSCLEROSIS
- Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells
- (2013) M Santoni et al. BRITISH JOURNAL OF CANCER
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Drug Repurposing for Gastrointestinal Stromal Tumor
- (2013) Z. Y. Pessetto et al. MOLECULAR CANCER THERAPEUTICS
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes
- (2013) Kimberly R. Doherty et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
- (2012) Kjell Magne Tveit et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
- (2012) Xian-ling Guo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
- (2012) R. Coriat et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers
- (2012) T Yamadori et al. ONCOGENE
- Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
- (2011) L. Alinari et al. BLOOD
- ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
- (2011) Katherine M. Aird et al. BREAST CANCER RESEARCH AND TREATMENT
- Erlotinib-Mediated Inhibition of EGFR Signaling Induces Metabolic Oxidative Stress through NOX4
- (2011) K. P. Orcutt et al. CANCER RESEARCH
- Immunotherapy for Renal Cell Carcinoma
- (2011) Momoe Itsumi et al. Clinical & Developmental Immunology
- Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells
- (2011) Shao-Ping Chang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant hep G2 cells through a mitochondria-dependent oxidative stress mechanism
- (2010) Jeng-Fong Chiou et al. CANCER BIOLOGY & THERAPY
- Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals
- (2010) Ghada M. Suddek CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines
- (2009) Laetitia Dahan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reactive oxygen species-dependent signaling regulates cancer
- (2009) Frank Weinberg et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- Rituximab sensitizes a Burkitt lymphoma cell line to cell killing by X-irradiation
- (2009) Min Fengling et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- Effects of Everolimus on Cytokines, Oxidative Stress, and Renal Histology in Ischemia-Reperfusion Injury of the Kidney
- (2009) Elif Suyani et al. RENAL FAILURE
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
- (2008) D Balin-Gauthier et al. BRITISH JOURNAL OF CANCER
- ERLOTINIB ACTIVATES MITOCHONDRIAL DEATH PATHWAYS RELATED TO THE PRODUCTION OF REACTIVE OXYGEN SPECIES IN THE HUMAN NON-SMALL CELL LUNG CANCER CELL LINE A549
- (2008) Xia Qian et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Within the next 10-15 years protons will likely replace photons as the most common type of radiation for curative radiotherapy
- (2008) Richard L. Maughan et al. MEDICAL PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started